G2PR has built a strong track record in helping our clients

“It has truly been a pleasure working together. Our work is now launched successfully. Hope to work together again soon.”
— Global Pricing Lead, Pharma
“Perfect partner.
Strategic, tactical, as well as operational.
Personalised support, highly collaborative.”
— Chair of Board, Multiple Consulting Firms

Ways G2PR has helped clients recently, a snapshot…

  • Glowing access

    Illuminating path together to better access

    PROJECT

    Manage cost-effectiveness modelling of large vendor for a novel molecule in a rare immunology disease

    APPROACH

    Understand work done thus far, and relationships

    Drive together to consensus on what good looks like

    Prepare for expert validation & NICE scientific advice

    OUTCOMES

    Global & UK teams achieved consensus on tough issue

    NICE scientific advice submission, on time

    Additional expert validation submitted

    Let's shine a light together
  • Strategic and tactical

    Strategic clarity, tactical course-correction

    PROJECT

    Evidence gap identification and a plan to address them 18 months pre-launch, in rare sarcoma

    APPROACH

    Understand current evidence and plan

    Gap identification, iteration, alignment, validation

    Prioritise evidence generation by need and impact

    OUTCOMES

    Place in therapy in key markets needed re-definition

    Choice of comparator would change in lockstep

    PFS to OS modelling, cross-over design mitigation next

    Let's bring clarity together
  • Values-aligned

    Values-aligned price and access guidance

    PROJECT

    Global price guidance development and access strategy generation as a true partner, in ultra-rare haematology

    APPROACH

    Understand price expectations and HEOR evidence

    Shape value narrative: match evidence, expectations

    Ensure ambitious price guidance while being achievable

    OUTCOMES

    Created together ambitious values-aligned guidance

    Ultra-rare nature of condition reflected practically

    Generated options that empower local affiliates

    Let's be proud of our work together
  • Relaunch strategy

    Relaunching paediatric neurology medicines

    PROJECT

    Relaunch strategy of two essential paediatric neurology drugs post patent expiry

    APPROACH

    Understand client capabilities

    Understand NHS prescribing

    Prioritise accounts with maximum potential

    OUTCOMES

    Client quickly deployed recommendations

    Sales increased beyond client expectations

    Sought similar in other European countries

    Let's reinvigorate your product together
  • Early access

    Pioneering early access scheme for a rare disease medicine

    PROJECT

    First early access to medicines scheme project for a mid-sized pharma bringing together local and global

    APPROACH

    Bring together cross-functional team colleagues

    Address uncertainty, build internal sponsorship

    Liaise with MHRA, NICE, NHS

    OUTCOMES

    Promising designation achieved in 7 weeks

    Stage 1 contracts signed in 5 weeks from then

    Stage 2 NHS engagement done before Phase 3 results

    Let's innovate together
  • Comprehensive review

    Comprehensive literature review - COVID therapies

    PROJECT

    Comprehensive literature review of COVID therapies to ensure health tech appraisal (HTA) preparedness

    APPROACH

    Defined protocol, through iterations

    Refined sensitive & specific searches

    Strict study selection, PRISMA diagrams

    OUTCOMES

    Enabled early identification of two relevant studies

    Ensured comparator preparedness

    Facilitated quicker submission

    Let us do the heavy lifting